CN Bio supports R&D efforts via fast-track Drug Metabolism and Safety Toxicity Testing Services that deliver human translatable insights from lead candidates in a few weeks and at lower cost than animal studies. By accessing the Company’s expertise and advanced in vitro liver-on-chip models, these Services enable researchers to step beyond standard in-house laboratory workflows for better informed pre-clinical decisions.
With their proprietary technology, the iLite® technology Svar can develop Report Gene Assays – that area cleverly designed, sensitive and specific cell based reporter-gene system with luciferase readout. Svar can develop assays for virtually any pharmaceutical target that allow an easy, rapid and accurate test format for a wide range of applications, such as Immunogenicity and Potency assays.
Next-generation sequencing research services for SARS-CoV-2 variant surveillance.
Moving quickly and safely through Phase I/IIa trials is critical to successful drug development. The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually.
At QPS, we realize that in today’s late stage drug development space you face many challenges. With our deep experience and broad global presence, QPS is in an excellent position to offer solutions to all of the above needs. With its site management & monitoring teams operating from 30 locations on three continents (Asia/Pacific, USA, and Europe), QPS has become a new strong player in Phase II/IV clinical research services.…
Data driven recommendations enabling you to make decisions on your lab equipment fleet with our suite of holistic lab and asset analytics delivered to you through the powerful mobile app and web portal. These tools help you to get access to cross lab and multi-vendor asset utilization data to make smarter decisions around how your lab assets are deployed, utilized, and managed throughout their life-cycle.
Spark OE spectrometer using CID (Charge Injection Device) for metals reasearch and inspection of incoming materials.Using the latest solid-state detector technology, the OneSpark is the only instrument capable of meeting the increasing metals analysis challenges of R&D, incoming inspection, and independent testing laboratories. The ability for a manufacturer to qualify a vast variety of incoming material, and an R&D or testing…
Millicell cell culture insert plates are a patented device designed to support cell growth and differentiation of endothelial and epithelial cell lines, including CaCo-2. The Millicell device is available with a 0.4 µm PCF and a variety of PET membrane pore sizes. The plate is designed for maximum user convenience and incorporates features such as apical assist for easier pipetting and basolateral access. To reduce the risk of…
